Technical Analysis - Hold - The idea would be to go long, but just wait the end of the price retracement before going long
Fundamental Analysis: Shares of Sorrento Therapeutics (NASDAQ:SRNE) rallied on Thursday after the biopharmaceutical company said it would take action against an organization it claims fraudulently attempted to manipulate its stock price. As of 3 p.m. EDT, Sorrento's stock was up 5% after rising as much as 16.6% earlier in the day.